Sign In
Buy ABT
$90.51
-0.0200 (-0.0221%)
At Close: Jun 24, 2026
Abbott Labs first-quarter results top estimates amid strong medical device sales
07:45am, Wednesday, 17'th Apr 2024
Abbott Laboratories on Wednesday reported first-quarter sales and profit that topped expectations amid strength in its medical-device business. The healthcare-products company reported first-quarter n
Abbott beats quarterly profit estimates on strong medical device sales
07:34am, Wednesday, 17'th Apr 2024
Abbott Laboratories beat Wall Street estimates for quarterly profit on Wednesday and raised the lower end of its forecast, as robust demand for medical procedures boosted sales of its devices, includi
Markets Mixed as Q1 Earnings, Powell Control News Headlines
07:16pm, Tuesday, 16'th Apr 2024
Wednesday morning brings us more Q1 earnings reports, including from Abbott Labs (ABT) and U.S. Bancorp (USB).
After Nearly A 20% Rise In Six Months Will Abbott Stock See Higher Levels Post Q1?
11:30am, Monday, 15'th Apr 2024
Abbott (NYSE: ABT) will report its Q1 2024 results on Wednesday, April 17. We expect the company to post revenue of $9.9 billion and earnings of $0.95 on a per share and adjusted basis, aligning with
3 Buy Rated Stocks to Consider as Earnings Approach
10:01pm, Friday, 12'th Apr 2024
Several top-rated Zacks stocks are standing out before their first-quarter earnings report next week and here are three to consider.
What's in Store for Abbott Laboratories (ABT) in Q1 Earnings?
10:56am, Friday, 12'th Apr 2024
Abbott (ABT) is likely to have progressed with its initiative to commercialize several biosimilars in emerging markets.
Ahead of Abbott (ABT) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
10:21am, Friday, 12'th Apr 2024
Evaluate the expected performance of Abbott (ABT) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for
7 Healthcare Stocks to Keep Your Portfolio in Tip-Top Shape
01:22pm, Wednesday, 10'th Apr 2024
With rising concerns in the market potentially forcing a strategic shift, investors may want to consider healthcare stocks. No matter what happens, people need access to health-related products and se
Abbott (ABT) Rises Higher Than Market: Key Facts
06:56pm, Tuesday, 09'th Apr 2024
The latest trading day saw Abbott (ABT) settling at $112.44, representing a +1.74% change from its previous close.
HAE vs. ABT: Which Stock Is the Better Value Option?
12:45pm, Tuesday, 09'th Apr 2024
Investors looking for stocks in the Medical - Products sector might want to consider either Haemonetics (HAE) or Abbott (ABT). But which of these two stocks is more attractive to value investors?
Abbott (ABT) Faces Low Testing Demand, Currency Headwinds
11:11am, Monday, 08'th Apr 2024
Abbott's (ABT) core laboratory diagnostics business is gaining strength on the continued success of the Alinity suite of diagnostics instruments, along with a broad test menu offering.
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
10:01am, Monday, 08'th Apr 2024
Zacks.com users have recently been watching Abbott (ABT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Abbott (ABT) Receives FDA's Approval for the TriClip TEER System
10:56am, Friday, 05'th Apr 2024
Abbott (ABT) receives FDA nod for TriClip, a first-of-its-kind device to repair a leaky tricuspid heart valve.
Is It Worth Investing in Abbott (ABT) Based on Wall Street's Bullish Views?
10:35am, Friday, 05'th Apr 2024
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
Abbott's (ABT) i-STAT TBI Cartridge Receives FDA Approval
12:21pm, Tuesday, 02'nd Apr 2024
Abbott's (ABT) i-STAT Alinity instrument uses whole blood to help assess patients with a suspected mild traumatic brain injury or concussion.
